NCT00334022View on ClinicalTrials.gov

Fuzeon Viral Decay Pilot Study

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

January 31, 2010

Conditions
HIV-1
Interventions
DRUG

enfuvirtide

1ml BID

Trial Locations (1)

M5B 1L6

Maple Leaf Medical Clinic, Toronto

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

Canadian Immunodeficiency Research Collaborative

OTHER

NCT00334022 - Fuzeon Viral Decay Pilot Study | Biotech Hunter | Biotech Hunter